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Abstract
Introduction and Objectives Certain Helicobacter pylori genotypes are associated with peptic ulcer disease; however, little
is known about associations between the H. pylori genotype and perforated peptic ulcer (PPU). The primary aim of this
study was to evaluate which genotypes are present in patients with PPU and which genotype is dominant in this population.
The secondary aim was to study the possibility of determining the H. pylori status in a way other than by biopsy.
Materials and Methods Serum samples, gastric tissue biopsies, lavage fluid, and fluid from the nasogastric tube were
collected from patients operated upon for PPU. By means of PCR, DEIA, and LIPA the presence of the “cytotoxin
associated gene” (cagA) and the genotype of the “vacuolating cytotoxin gene” were determined.
Results Fluid from the nasogastric tube was obtained from 25 patients, lavage fluid from 26 patients, serum samples from
20 patients and biopsies from 18 patients. Several genotypes were found, of which the vacA s1 cagA positive strains were
predominant. Additionally, a correlation was found between the H. pylori presence in biopsy and its presence in lavage fluid
(p=0.015), rendering the latter as an alternative for biopsy. Sensitivity and specificity of lavage fluid analysis were 100%
and 67%, respectively.
Conclusion This study shows the vacA s1 cagA positive strain is predominant in a PPU population. The correlation found
between the H. pylori presence in biopsy and its presence in lavage fluid suggests that analysis of the lavage fluid is
sufficient to determine the H. pylori presence. Risks associated with biopsy taking may be avoided.
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Introduction
Over the past decades the incidence of perforated peptic ulcer
(PPU) has declined in the western world. However, with an
incidence varying between two and 10 per 100,000, it still is a
problem in modern society.1 Moreover, mortality rates caused
by gastric and duodenal ulcer perforation vary between 10
and 40% and zero and 10% respectively, and is higher among
elderly patients.2,3 Several risk factors for PPU have been
described such as smoking, alcohol abuse, and history of
peptic ulcer disease (PUD).2 However, the main pathogenic
factors are considered to be the use of non-steroidal anti-
inflammatory drugs (NSAID) and the presence of H. pylori.2
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Helicobacter pylori are widespread bacteria, with a
prevalence ranging from 25% in the industrialized world
to more than 70% in developing countries.4,5 Most infected
people remain asymptomatic; however, a small group of
carriers will develop PUD.
Of patients who have developed PPU, 70% will test
positive for H. pylori,2 suggesting the pathogenesis of
perforation is associated with the presence of H. pylori. In
addition, it is shown that different genotypes of H. pylori
are associated with different clinical manifestations like
PUD and gastric cancer.6,7 Two well-known H. pylori genes
that have been associated with PUD are the cytotoxin-
associated gene (cagA) and the vacuolating cytotoxin gene
(vacA).6,8–10
VacA is present in all H. pylori strains and is associated
with gastritis, PUD, and gastric carcinoma.10–12 It encodes
for a vacuolating cytotoxin that causes epithelial cell injury
and interferes with the immune system.13,14 VacA contains
at least two variable regions, the signal peptide (s)-region
and the middle (m)-region. The s-region contains two
allelic types, s1 and s2. The s1 strain has several subtypes,
being s1a, s1b, and s1c.15 Two allelic types exist for the
m-region, m1 and m2. The latter has two subtypes, m2a and
m2b.16
CagA is considered a marker for a genomic pathogenic-
ity (cag) island that is associated with enhanced virulence.17
If PPU is associated with a specific H. pylori genotype it
may be feasible to limit the patients undergoing antibiotic
therapy to those who have this genotype. When this
specific type is not present, another cause of PPU should
be looked for and antibiotic therapy should not be started.
This would mean cost reduction and, probably, a reduction
in the speed of the development of antibiotic resistance.
Currently, gastric biopsy during endoscopy is a generally
accepted method to diagnose H. pylori infection. However,
patients with PPU will not undergo endoscopy but will
generally be operated upon immediately. Taking a biopsy
intraoperatively implicates a higher risk of bleeding and
more difficult closure of the defect. Therefore, surgeons are
reluctant to take a biopsy.
The primary aim of this study was to evaluate which
genotypes are present in patients with PPU and if a
genotype is dominant in this population. The secondary
aim was to study the possibility of determining the H.
pylori status in a manner other than by gastric tissue biopsy.
Methods
From 30 consecutive patients operated on for PPU serum
samples, gastric tissue biopsies, lavage fluid, and fluid from
the nasogastric tube were collected. These patients were
treated in five different medical centers throughout the
Netherlands. In each of these centers approval of the
medical ethical committee was obtained. Immediately after
collection, the materials were frozen at −20°C. One
researcher performed the analysis and genotyping. For H.
pylori genotyping, the presence of cytotoxin-associated
gene (cagA) and the s- and m-region genotypes of the
vacuolating cytotoxin gene (vacA) were determined.
DNA was isolated according to Boom’s method as
described previously.18 A guanidine thiocyanate (GuSCN)
solution was added to the collected material to induce lysis
of the bacteria, releasing their DNA. After addition of the
silica particles (Celite) the suspension was centrifuged. The
silica particles, with the attached DNA, were washed with
subsequently GuSCN-containing washing buffer, ethanol
70% and acetone. After drying, the DNA was eluted in an
aqueous low salt buffer. The isolated DNA was amplified
by means of polymerase chain reaction (PCR) and
subsequently the presence of cagA and different types of
vacAwere analyzed by means of reverse hybridization on a
strip (32). This assay consists of a nitrocellulose strip that
contains dT-tailed oligonucleotide probes immobilized as
parallel lines. For each strain, 10 μl of each PCR product
(containing biotin at the 5′ end of each primer) was
denatured by the addition of an equal amount of 400 mM
NaOH and 10 mM EDTA in a plastic trough. After 5 min,
1 ml of prewarmed hybridization solution (2× SSC [1× SSC
is 0.15 M NaCl plus 0.015 M sodium citrate], 50 mM Tris–
HCl [pH 7.5], 0.1% SDS) was added, and a strip was
submerged and incubated in a shaking water bath at 50°C
for 1 h. The strips were washed with 2 ml of 2× SSC-0.1%
SDS for 30 min at 50°C. Subsequently, the strips were
rinsed three times in phosphate buffer, and conjugate
(streptavidin–alkaline phosphatase) was added. After incu-
bation at room temperature for 30 min, the strips were
rinsed again and 4-nitroblue tetrazolium chloride and
5-bromo-4-chloro-3-indolylphosphate substrate was added.
Hybrids are visible as purple probe lines. Interpretation of
the hybridization patterns was performed visually. As a
control, a β-globin PCR was performed. Patient related
factors were obtained prospectively. Statistical analysis was
performed with SPSS for Windows, version 11.0.
Results
A total of 30 patients were included of whom nine were
women. The average age was 65 years, varying between 40
and 87. Ten patients (33.3%) were operated laparoscopi-
cally. The perforation was found prepyloric in 11 patients,
at the site of the pylorus in eight patients and postpyloric in
11 patients.
A total of five (16.7%) patients had a history of PUD.
Ten patients (33.3%) used NSAID’s, two patients (6.7%)
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used steroids, three patients (10.0%) used acid reducers,
and one patient (3.3%) used a proton pump inhibitor (PPI)
before admission to the hospital. The average hospital stay
was 11.9 days, varying between 3 and 37 days.
Fluid from the nasogastric tube was obtained from 25
patients, lavage fluid from 26 patients, serum samples from
20 patients, and ulcer biopsies from 18 patients. The results
of the genotyping are depicted in Table 1.
The β-globin determination was performed as a control.
In nine samples of nasogastric tube fluid and in two
samples of lavage fluid it was negative, rendering these
results as unreliable. Therefore, these results were excluded
from further analysis.
Table 2 represents the frequency of the individual genes
and the allelic types found in the different samples by
means of PCR and LiPA.
These tables show that for vacA the allelic type s1 is
predominantly present in all three types of samples. In the
s1 positive strains, subtype s1a is predominant as depicted
in Table 3.
With regard to the middle region of vacA the incidence
of m1 allelic type is slightly higher; however, the difference
Table 1 Helicobacter pylori Status and Genotype
The colors represent the β-globin and H. pylori status of the patient.
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is less outspoken compared to s1. The m2a was the only
subtype that was found in the samples. In three samples, the
genotyping was incomplete (Tables 1 and 2), meaning that
determination of the middle region was not possible. This
was most likely caused by the small number of bacteria
present in those samples.
With regard to the secondary aim of this study, analyzing
possibilities to diagnose H. pylori presence in another
fashion than through biopsy, the H. pylori status found in
each type of sample was compared. A correlation was
found between the H. pylori presence in biopsy and its
presence in lavage fluid (Fisher’s exact test, p=0.015),
indicating lavage fluid is a valid alternative for determina-
tion of H. pylori infection.
The sensitivity and specificity of the lavage fluid
analysis was calculated, considering biopsy as a golden
standard. Fourteen patients, of which the lavage fluid as
well as the biopsy was analyzed, were included into this
calculation (patients 2, 4, 5, 6, 8, 10, 15, 23–25, 27–30,
Table 1), which is shown in Table 4. Of the remaining
patients, either the biopsy or the lavage fluid was missing;
therefore, these data cannot be used in the sensitivity/
specificity calculation.
The sensitivity was 100%, which means that in case of
the presence of H. pylori in the biopsy specimen, the lavage
fluid analysis detected it in 100% of cases. The specificity
of lavage fluid analysis was 66.7%, which means the
chance for false-positives is over 30%. With regard to
gender, age, BMI, history of PUD, location of perforation,
complications after procedure, and use of steroids, PPI, or
antihistaminic medication, no statistically significant corre-
lation was found.
Discussion
Concerning the role of H. pylori in the pathogenesis of
PPU, some studies have been reported comparing the
prevalence of H. pylori infection in patients with PPU to
the prevalence in controls. They appear to be similar,
suggesting that other factors like NSAID use play a
role.19–21 However, the substantial genetic heterogeneity
Table 3 Distribution of the vacA s1 Subtypes
VacA Subtype Fluid from Naso-Gastric Tube Lavage Fluid Gastric Tissue Biopsy Control Non-Ulcer
No. % No. % No. % %
S1a 8 80.0 13 92.9 5 71.4 81.3
S1b 2 20.0 1 7.1 2 28.6 18.7
S1c 0 0 0 0 0 0 0
Total 10 100 14 100 7 100 100
The s1a subtype is predominant in all sample types.
The “Control non ulcer” column represents the frequencies, found by van Doorn et al., in a population without PUD and is added to allow easy
comparison.
Table 2 Frequencies of Individual Genes and Allelic Types
Genotype Fluid from Naso-Gastric Tube Lavage Fluid Gastric Tissue Biopsy Control Non-Ulcer
No. % No. % No. % %
VacA s1 10 90.9 14 77.8 7 77.8 46.9
VacA s2 0 0 1 5.5 1 11.1 38.4
VacA multiple 1 9.1 3 16.7 1 11.1 14.7
Total 11 100 18 100 9 100 100
VacA m1 6 54.5 9 50.0 5 55.6 29.4
VacA m2 4 36.4 8 44.4 3 33.3 55.9
VacA incomplete genotype 1 9.1 1 5.6 1 11.1 0 (14.7 % incomplete)
Total 11 100 18 100 9 100 100
CagA positive 9 81.8 14 77.8 5 55.6 47.1
Total 11 100 18 100 9 100 100
“VacA multiple” means that more than one allelic type or subtype has been found in one sample.
In each different type of sample one incomplete genotype occurred, which is indicated as “vacA incomplete”. The “Control non ulcer” column
represents the frequencies, found by van Doorn et al., in a population without PUD and is added to allow easy comparison.
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of H. pylori that has been revealed over the years leads to
the hypothesis of a specific genotype causing PPU.5
Controls might test positive for H. pylori, but not develop
PPU because it would not be this specific genotype that is
isolated. This study of a selected population of patients, all
with PPU, shows a limited diversity of H. pylori genotypes
as represented by Table 1.
VacA s1 strains are predominantly present in the three
sample types of which s1a is the predominant subtype.
Concerning the vacA m-region, the m1 strains are found in
a majority of cases; however, the difference is less
convincing than for vacA s1. Except for the biopsy samples,
the cagA positive strains were predominantly present is this
population. In the biopsy samples, the frequency of cagA-
positive strains seemed to be low; however, this number is
distorted because in two of nine positive biopsies, a decent
comparison with the other samples was not possible. In
patient 5, genotyping of the lavage fluid and nasogastric
tube fluid was incomplete, and for patient 15, the opposite
was the case. This means that the actual incidence should
be 71.4 % (5/7).
Summarising, these results shows that the vacA s1,
cagA-positive strains were predominant in this population
of patients with PPU. This finding is in accordance with
literature reporting correlations between the presence of
vacA s1, cagA-positive strains and PUD.6,10 Therefore,
detection of the genotype vacA s1 does not specifically
predict PPU; nevertheless, clinicians should be aware of
this association.
In Tables 2 and 3 the genetic distribution in a Dutch
population without PUD, as found by van Doorn et al., are
added for comparison. The frequencies found in this study
for vacA s1, m1, and cagA-positive strains are clearly
higher than in the non-PUD group, confirming the
aforementioned hypothesis. However, with regard to the
subtypes, Table 3 shows an almost similar distribution of
frequencies, suggesting that determination of the allelic
subtype is of less importance.
In only 60% of patients biopsies could be analyzed. The
reason for missing 40% is the restraint of the surgeon to
take a biopsy when risk of bleeding and more difficult
closure of the defect was estimated to be too high, which
emphasizes the importance of finding an alternative. To do
so, the H. pylori status of the patient as determined by
biopsy was compared to the status as determined by
analysis of nasogastric tube fluid, lavage fluid, and serum.
A statistically significant correlation was found between the
H. pylori status in biopsy and its status in lavage fluid
(Fisher’s exact test, p=0.015). This finding suggests that
determination of the H. pylori status can be done with
lavage fluid as well, obviously without any risk of bleeding
and closure related difficulties. The sensitivity is 100%, but
the specificity is 66.7%. This could mean the chance for
false-positives is over 30%, which is not optimal and could
lead to therapy overshoot. However, considering the fact
that with the lavage a larger area is sampled, rendering the
chance of positive test results higher than in biopsy, it is
more likely to find false negative biopsy results. This could
lead to a therapy undershoot, which obviates the impor-
tance having an alternative for a biopsy.
In only two samples, both nasogastric tube fluids, a H.
pylori genotype was isolated, while β-globin tested
negative. In nine samples (seven nasogastric tube fluid,
two lavage fluid) both β-globin and H. pylori tested
negative. This means that either no humane cells were
present in the samples, which is unlikely, or that an error in
the PCR procedure had occurred. Because this was unclear
these results were considered unreliable. Therefore, it still
could be possible that nasogastric tube fluid is a good
alternative for determining the H. pylori status as well.
Overall, these results are positive, however they should
be confirmed in a larger population.
Conclusion
This study shows that in a population of 30 patients with
PPU, vacA s1, cagA positive strains are predominant. This
finding is in accordance with literature reporting correla-
tions between the presence of vacA s1, cagA-positive
strains, and PUD. Therefore, detection of this genotype
does not specifically predict PPU. Nevertheless, clinicians
should be aware of this association.
This study shows as well that it is feasible to use
intraoperative lavage fluid to determine the H. pylori status
of the patient, implicating that biopsies, with a risk of
bleeding and more difficult closure of the defect, are not
necessary anymore. In addition, considering the fact that a
larger area is sampled with lavaging, biopsies may result in
more false negative results leading to insufficient therapy.
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Table 4 Calculation of Sensitivity and Specificity of Lavage Fluid
Analysis
Biopsy
Lavage fluid + – Total
+ 8 2 10
– 0 4 4
Total 8 6 14
Sens 8/8=1 Spec 4/6=0.67
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